Overview
Sponsor-declared trial summary
Phase
Human pharmacology (Phase I) - Other
Status
Ongoing, recruiting
Participants planned
20
Countries
1
Sites
1
Alzheimer’s Disease (AD)
Key facts
- Sponsor
- F. Hoffmann-La Roche AG
- Participant type
- Patients, Healthy volunteers
- Age range
- 18-64 years, 65+ years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Nervous System Diseases [C10]
- Trial duration
- 10 Dec 2024 → ongoing
- Decision date (initial)
- 2024-10-15
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- Yes
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
Alzheimer’s Disease (AD)
| Version | Level | Code | Term | System organ class |
|---|---|---|---|---|
| 20.0 | LLT | 10001896 | Alzheimer's disease | 10029205 |
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
F. Hoffmann-La Roche AG
- Sponsor organisation
- F. Hoffmann-La Roche AG
- Address
- Grenzacherstrasse 124
- City
- Basel
- Postcode
- 4058
- Country
- Switzerland
Scientific contact point
- Organisation
- F. Hoffmann-La Roche AG
- Contact name
- Trial Information System - TISL
Public contact point
- Organisation
- F. Hoffmann-La Roche AG
- Contact name
- Trial Information System - TISL
Locations
1 EU/EEA country · 1 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Netherlands | Ongoing, recruiting | 20 | 1 |
| Rest of world | — | 0 | — |
Investigational sites
Stichting Amsterdam UMC
Department of Radiology and Nuclear Medicine, De Boelelaan 1117, 1081 HV, Amsterdam
Country notifications
Trial-start, recruitment-start, end and early-termination notifications submitted per Member State
| Country | Trial start | Trial end | Recruitment start | Recruitment end | Early termination |
|---|---|---|---|---|---|
| Netherlands | 2024-12-10 | 2025-03-05 |
Application history
5 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2024-08-07 | Netherlands | Acceptable 2024-10-15
|
2024-10-15 |
| 2 | NON SUBSTANTIAL MODIFICATION | NSM-1 | 2025-02-13 | Netherlands | Acceptable 2024-10-15
|
2025-02-13 |
| 3 | NON SUBSTANTIAL MODIFICATION | NSM-2 | 2025-03-21 | Netherlands | Acceptable 2024-10-15
|
2025-03-21 |
| 4 | SUBSTANTIAL MODIFICATION | SM-2 | 2025-07-18 | Netherlands | Acceptable 2025-08-15
|
2025-08-15 |
| 5 | NON SUBSTANTIAL MODIFICATION | NSM-3 | 2026-04-29 | Netherlands | Acceptable 2025-08-15
|
2026-04-29 |